Skip to main content

stock

ARQT · Arcutis Biotherapeutics, Inc.

What Arcutis Biotherapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live ARQT price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ARQT.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
125,691,961 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
7.4%
Net
6.2%

Returns

ROE
12.9%
ROA
5.8%

Health

Current ratio
2.9x
Debt/equity
0.5x

Deep value

NCAV
$199.71M
NCAV per share
$1.59
Price/NCAV
Locked
NNWC
-$98.03M
NNWC per share
-$0.78
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$129.86M—Gross profit: unreported by this company.$16.43M$15.01M
10-Q filed 2026-08-05
2026-03-31$105.40M—Gross profit: unreported by this company.-$9.09M-$11.29M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$127.50M—Gross profit: unreported by this company.$18.39M$17.39M
DEF 14A filed 2026-04-21
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$99.22M—Gross profit: unreported by this company.$8.53M$7.41M
10-Q filed 2025-10-28
2025-06-30$81.50M—Gross profit: unreported by this company.-$14.61M-$15.89M
10-Q filed 2026-08-05
2025-03-31$63.85M—Gross profit: unreported by this company.-$24.53M-$25.06M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$69.36M—Gross profit: unreported by this company.-$7.63M-$10.79M
DEF 14A filed 2026-04-21
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$44.76M—Gross profit: unreported by this company.-$39.07M-$41.54M
10-Q filed 2025-10-28
Assets
$488.54M
Equity
$220.58M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$372.07M-$12.23M-$16.14M-$6.31M
2024-12-31$166.54M-$128.40M-$140.04M-$112.30M
2023-12-31$29.19M-$241.10M-$262.14M-$247.49M
2022-12-31$3.69M-$301.63M-$311.46M-$258.05M
2021-12-31$0-$206.53M-$206.36M-$175.62M
2020-12-31$0-$136.65M-$135.68M-$113.35M
2019-12-31—-$43.13M-$42.00M-$43.13M
2018-12-31—-$19.73M-$19.25M-$14.09M

Company filings

since Wed Feb 25

events

  • Results, Executive or director change

    ResultsExecutive or director change
    Aug 58-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Jul 168-K
  • Shareholder vote results, Other event

    Shareholder vote resultsOther event
    Jun 98-K
  • 8-K

    May 68-K
  • Results

    Results
    Feb 258-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    12/8/20258-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Matsuda Masaru

    See Remarks

    Sale$91,853

    Sep 18, 4:17 PM ET

  • Welgus Howard G.

    Director

    Sale$114,371

    Sep 17, 4:06 PM ET

  • Matsuda Masaru

    See Remarks

    Sale$249,986

    Sep 10, 7:24 PM ET

  • Curran Terrie

    Director

    Sale$956,123

    Aug 28, 5:40 PM ET

  • Curran Terrie

    Director

    Sale$27,912

    Aug 24, 4:19 PM ET

All insider trades for ARQT

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

  • Point72

    Period Tue 30 Jun 2026

    0.0%Trimmed

All funds

News

Stories that named ARQT, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ARQT.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ARQT.

nakagai

Signals on ARQT come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ARQT board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.